NON APPLICABILITY CERTIFICATE OF REGULATION 24(A) FOR THE QUARTER/ YEAR ENDED 31.03.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beryl Drugs Ltd has informed the Bombay Stock Exchange that the Annual Secretarial Compliance Report under SEBI's Regulation 24A of the LODR Regulations does not apply to the company for the financial year ended 31 March 2025. The company is claiming exemption under Regulation 15(2) of the SEBI LODR Regulations, 2015, which exempts listed entities whose paid-up equity share capital does not exceed Rs. 10 crore and whose net worth does not exceed Rs. 25 crore as on the last day of the previous financial year. As a result, the company is not required to submit the Annual Secretarial Compliance Report for FY25. The communication was dated 11 April 2025 and signed by the company based in Indore, Madhya Pradesh.
This is a routine compliance disclosure and signals that Beryl Drugs is a very small listed entity (below Rs. 10 crore paid-up capital and Rs. 25 crore net worth). It has no material impact on shareholders or the stock price, but it confirms the company falls in the micro/small-cap bracket with relaxed corporate governance reporting requirements.